Drug Type Bispecific antibody |
Synonyms Bispecific anti-GD2/anti-B7-H3 monoclonal antibody, INV 721, INV-721 |
Target |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), GD2 inhibitors(Disialoganglioside GD2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroblastoma | Preclinical | US | 04 Mar 2024 |